Vimovo

Vimovo is a pain reliever in the form of a tablet for oral consumption, with delayed release of esomeprazole magnesium and naproxen, produced by AstraZeneca.[1]

Vimovo is FDA approved for use for osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.[2]

It is intended to decrease the risk of gastric ulcers from treatment with nonsteroidal anti-inflammatory drugs.

References

  1. ↑ http://www.felleskatalogen.no/medisin/vimovo-astrazeneca-571825
  2. ↑ http://www.vimovo.com/arthritis-pain/


This article is issued from Wikipedia - version of the Tuesday, April 19, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.